Company / Operating Cash Flow
Sonoma Pharmaceuticals, Inc. Operating Cash Flow History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$88.0K
FY2026
5-year range
-$6.2M / -$88.0K
FY2022-FY2026
Trend
+96.3%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$12M in FY2019 to -$88,000 in FY2026.
Based on SEC 10-K filings.
-$88,000 in FY2026.
Improved from -$6M to -$88,000 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, operating cash flow increased 96.3% year-over-year.
- Lowest operating cash flow in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -$88.0K | +96.3% |
| FY2025 | -$2.4M | +61.0% |
| FY2024 | -$6.2M | -44.8% |
| FY2023 | -$4.2M | -25.8% |
| FY2022 | -$3.4M | +26.4% |
| FY2021 | -$4.6M | +60.8% |
| FY2020 | -$11.7M | +5.8% |
| FY2019 | -$12.4M | -52.3% |
| FY2018 | -$8.2M | +6.6% |
| FY2017 | -$8.7M | -30.7% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026